Literature DB >> 4173396

Marrow-suppressing factors in the blood in pure red-cell aplasia, thymoma and Hodgkin's disease.

E O Field, M N Caughi, N M Blackett, D W Smithers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4173396     DOI： 10.1111/j.1365-2141.1968.tb01516.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  [Clinical and erythrokinetic findings in isolated erythropoietic aplasia before and after successful corticosteroid therapy].

Authors:  K Havemann; H Kuni; P Schmitz-Moormann
Journal:  Blut       Date:  1973-03

2.  Pure red cell aplasia: successful treatment with cyclophosphamide.

Authors:  J Vilan; K Rhyner; A M Ganzoni
Journal:  Blut       Date:  1973-01

3.  [Anemia caused by erythroblastopenia in adult age].

Authors:  D Böttcher; D Maas; F Wendt; H Schubothe
Journal:  Klin Wochenschr       Date:  1970-01-15

4.  Phenytoin-associated reversible red cell aplasia.

Authors:  K I Pritchard; I C Quirt; W J Simpson; J F Fleming
Journal:  Can Med Assoc J       Date:  1979-12-08       Impact factor: 8.262

5.  Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient.

Authors:  H L MacKechnie; A H Squires; M Platts; W Pruzanski
Journal:  Can Med Assoc J       Date:  1973-10-20       Impact factor: 8.262

6.  Bone marrow erythropoiesis in the anemia of infection, inflammation, and malignancy.

Authors:  S Zucker; S Friedman; R M Lysik
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

7.  Erythropoiesis and iron metabolism in Hodgkin's disease.

Authors:  S Al-Ismail; I Cavill; I H Evans; A Jacobs; C Ricketts; D Trevett; J A Whittaker
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.